Cabrera-Serrano, A.J.; Sánchez-Maldonado, J.M.; ter Horst, R.; Macauda, A.; García-Martín, P.; Benavente, Y.; Landi, S.; Clay-Gilmour, A.; Niazi, Y.; Espinet, B.;
et al. Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression? Int. J. Mol. Sci. 2023, 24, 8005.
https://doi.org/10.3390/ijms24098005
AMA Style
Cabrera-Serrano AJ, Sánchez-Maldonado JM, ter Horst R, Macauda A, García-Martín P, Benavente Y, Landi S, Clay-Gilmour A, Niazi Y, Espinet B,
et al. Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression? International Journal of Molecular Sciences. 2023; 24(9):8005.
https://doi.org/10.3390/ijms24098005
Chicago/Turabian Style
Cabrera-Serrano, Antonio José, José Manuel Sánchez-Maldonado, Rob ter Horst, Angelica Macauda, Paloma García-Martín, Yolanda Benavente, Stefano Landi, Alyssa Clay-Gilmour, Yasmeen Niazi, Blanca Espinet,
and et al. 2023. "Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?" International Journal of Molecular Sciences 24, no. 9: 8005.
https://doi.org/10.3390/ijms24098005
APA Style
Cabrera-Serrano, A. J., Sánchez-Maldonado, J. M., ter Horst, R., Macauda, A., García-Martín, P., Benavente, Y., Landi, S., Clay-Gilmour, A., Niazi, Y., Espinet, B., Rodríguez-Sevilla, J. J., Pérez, E. M., Maffei, R., Blanco, G., Giaccherini, M., Cerhan, J. R., Marasca, R., López-Nevot, M. Á., Chen-Liang, T.,
... Sainz, J.
(2023). Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression? International Journal of Molecular Sciences, 24(9), 8005.
https://doi.org/10.3390/ijms24098005